Consumer Edge Boosts Rating On Clorox Company (CLX) To "Outperform"

Marco Green
November 14, 2017

American Beacon Advisors Inc. acquired a new stake in shares of Clorox Company (The) in the first quarter worth approximately $104,000.

When investors engage in short selling or "shorting a stock", they actually borrow shares from an existing owner, sell the borrowed shares at market price, and take the cash. First National Trust Co.'s holdings in Clorox Company (The) were worth $1,349,000 at the end of the most recent reporting period. Dimensional Fund Advisors Lp added to its stake by buying 939 shares an increase of 0.2% from 06/30/2017 to 09/30/2017. Ubs Asset Management Americas Inc now controls 2,877 shares valued at $379,505,000. The stock plunged -0.9 percent over the past quarter, while surged 3.34 percent over the past six months. Moreover, Oppenheimer Asset Management Incorporated has 0.09% invested in Clorox Co (NYSE:CLX). Ameriprise Financial Inc. now owns 1,341,272 shares of the company's stock worth $178,433,000 after purchasing an additional 265,200 shares in the last quarter. James Investment Research Inc sold 10,320 shares as the company's stock declined 10.55% while stock markets rallied. The PE ratio shows how the company is performing in its financial terms compared to its competitors. Institutional investors and hedge funds own 71.58% of the company's stock. On November 10 the company was upgraded to "Outperform" from "Neutral" in a report issued by Consumer Edge. Morgan Stanley has "Equal-Weight" rating and $128 target. On October 8 Royal Bank Of Canada held the stock rating at "Hold" targeting a price of $115.00. Jefferies Group LLC reiterated a "hold" rating and issued a $137.00 price objective (up previously from $136.00) on shares of Clorox Company (The) in a report on Wednesday, August 9th. Zacks Investment Research lowered shares of Clorox Company (The) from a "buy" rating to a "hold" rating in a research note on Monday, July 31st. The rating was maintained by BMO Capital Markets on Friday, May 5 with "Buy". November 1 investment analysts at Jefferies Group LLC made no change to the stock rating of "Hold" projecting a price of $132.00. The volume of the company in the last trading session was 1.21 Million. Company insiders own 0.74% of the company's stock. 1 analysts call it Underweight, while 0 think it is Overweight. The relative volume of the stock is 1.31, while its market cap is $17.43 Billion. The company's revenue for the quarter was up 4.0% on a year-over-year basis. analysts expect that Clorox Company will post 5.58 earnings per share for the current year.

According to 13 analysts, the Average Revenue Estimate for the current Fiscal quarter is $1.65 Billion and the Low Revenue estimate is $1.63 Billion, while the High Revenue estimate is $1.66 Billion. Clorox Company (The) had a net margin of 11.84% and a return on equity of 161.59%.

Relative strength index (RSI-14) for The Clorox Company (CLX) is at 64.04. The company reported $1.36 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $1.42 by $0.06. Investors of record on Wednesday, October 25th will be paid a $0.84 dividend. The ex-dividend date of this dividend was Tuesday, October 24th. This represents a $3.36 annualized dividend and a yield of 2.54%. At The Clorox Company (CLX), there are now 904 institutional holders with a total of 93,900,666 shares.

COPYRIGHT VIOLATION NOTICE: "Clorox Company (The) (CLX) Shares Bought by First National Trust Co." was originally published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and worldwide trademark and copyright law.

In other news, EVP James E. Foster sold 9,861 shares of the business's stock in a transaction on Wednesday, August 23rd.

Rockwell Collins Inc. (COL) analysts on average have given a price target of $133.23 on COL stock. Following the sale, the senior vice president now owns 20,614 shares in the company, valued at approximately $2,862,666.18. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, COO Dawn C. Willoughby sold 2,158 shares of the business's stock in a transaction on Tuesday, August 29th. The shares were sold at an average price of $138.87, for a total value of $1,280,798.01. The disclosure for this sale can be found here. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company. Corporate insiders own 1.00% of the company's stock.

The Clorox Company shares increased 5.75 percent over the past week and rose 2.89 percent over the previous month. The Firm sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors.

Other reports by Click Lancashire

Discuss This Article